Accelerate Neurodegeneration Trials With Biomarker Strategies, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how biomarker strategies can support earlier disease detection and more efficient neurodegeneration trials. The featured speakers will discuss biological, imaging, digital and wearable biomarkers for patient selection, disease monitoring and treatment-response assessment. Attendees will also explore how these tools can inform trial design, precision medicine approaches and data-driven CNS drug development.

TORONTO, Sept. 16, 2026 /PRNewswire/ -- Neurodegenerative disease research is entering a transformative era, driven by significant advances in biomarker science, digital health technologies and precision medicine. As the prevalence of disorders such as Alzheimer's disease, Parkinson's disease and other neurodegenerative conditions continues to grow, there is an increasing need for innovative tools that can improve disease detection, optimize clinical trial design and accelerate the development of effective therapies.

This webinar will explore how emerging biomarkers are reshaping the future of clinical research and therapeutic development. From biological and imaging biomarkers to digital and wearable technologies, these advances are providing new opportunities to identify disease earlier, better characterize patient populations, monitor disease progression and evaluate treatment response with greater precision. By generating more objective and actionable data, biomarkers are helping researchers and sponsors make more informed decisions throughout the drug development process.

Through presentations from leading experts in the field, attendees will gain valuable insights into the evolving role of biological, digital and wearable markers in neurodegeneration research. Speakers will discuss how these technologies are supporting more efficient clinical trials, enhancing patient selection strategies, enabling personalized treatment approaches and contributing to the development of next-generation therapies.

The webinar will also highlight real-world applications, operational considerations and emerging trends shaping the future of CNS research. Participants will learn about the opportunities and challenges associated with integrating innovative biomarker strategies into research programs and clinical development initiatives.

This session will provide a practical and forward-looking perspective on the advances transforming neurodegenerative disease research. As the field moves toward more precise, data-driven and patient-centered approaches, understanding the role of biomarkers and digital innovation will be essential to advancing the next generation of treatments and improving outcomes for patients worldwide.

Register for this webinar to learn how biomarker strategies in neurodegeneration can improve disease detection, clinical trial design and treatment monitoring.

Join Bob Dagher, MD, Chief Medical Officer, Clinilabs; Robin Wolz, PhD, Chief Scientific Officer (CSO) and Chief Medical Officer (CMO), IXICO; Brian Murphy, PhD, Co-Founder and Chief Scientific Officer, Cumulus Neuroscience Ltd, Cumulus Neuro; and Dr. Bill Byrom, VP, Product Intelligence and Positioning, Principal, eCOA Science, Senior Visiting Professor, Nottingham Trent University, Signant Health, for the live webinar on Monday, October 5, 2026, at 12pm EDT (6pm CEST / EU-Central).

For more information, or to register for this event, visit Accelerate Neurodegeneration Trials With Biomarker Strategies.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com

For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:

Soumya Shashikumar

Tel: +1 (416) 977-6555 x371

Email: [email protected]

SOURCE Xtalks